Back

Effects of mineralocorticoid receptor antagonists on diastolic function and exercise capacity in heart failure with preserved ejection fraction: a meta-analysis of randomized controlled trials

27 August 2018 (08:30 - 12:30)
Organised by:
Congress Presentation Part of: Poster Session 4 - Chronic heart failure – pathophysiology and mechanisms Heart Failure with Preserved Ejection Fraction (HFpEF) ESC Premium Access ESC Congress 2018

About the speaker

Photo
Associate Professor Hidekatsu Fukuta

Nagoya City University Graduate School of Medical Sciences, Nagoya (Japan)

21 More presentations in this session

Presentation thumbnail
Doctor K. Kopeva (Tomsk, RU)
Abstract Slides
Presentation thumbnail
Doctor Q. Wang (Lanzhou, CN)
Abstract
Presentation thumbnail
Associate Professor M. Marketou (Heraklion, GR)
Abstract Slides
Presentation thumbnail
Doctor M. Kurkina (Moscow, RU)
Abstract Slides
Presentation thumbnail
Professor R. Shoucri (Kingston, CA)
Abstract Slides

Access the full session

Session thumbnail
Poster Session 4 - Chronic heart failure – pathophysiology and mechanisms

The Event

Event poster

ESC Congress 2018

27 August 2018 08:30 CET
You may be interested in
thumbnail
Congress Presentation
The mineralocorticoid receptor antagonists in heart failure with preserved ejection fraction
29 June 2021
thumbnail
Congress Session
Editor's Choice: report from the heart failure sections of ESC Journal Family and overview of the ESC Textbook of Heart Failure
18 May 2025
thumbnail
Congress Presentation
Effects of SGLT2 inhibitors on heart failure symptoms, quality of life and exercise capacity in patients with heart failure and preserved ejection fraction: A meta-analysis
1 December 2022
thumbnail
Congress Presentation
Exercise capacity in arterial hypertension: left ventricular posterior wall thickness as a structural determinant of reduced peak oxygen consumption in preserved ejection fraction phenotype
30 August 2026

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources